WO2020231030A3 - Composition comprising lactobacillus acidophilus for preventing, alleviating, or treating nervousness, formication, insomnia, vertigo, or fatigue in menopausal women - Google Patents

Composition comprising lactobacillus acidophilus for preventing, alleviating, or treating nervousness, formication, insomnia, vertigo, or fatigue in menopausal women Download PDF

Info

Publication number
WO2020231030A3
WO2020231030A3 PCT/KR2020/005262 KR2020005262W WO2020231030A3 WO 2020231030 A3 WO2020231030 A3 WO 2020231030A3 KR 2020005262 W KR2020005262 W KR 2020005262W WO 2020231030 A3 WO2020231030 A3 WO 2020231030A3
Authority
WO
WIPO (PCT)
Prior art keywords
formication
nervousness
vertigo
insomnia
fatigue
Prior art date
Application number
PCT/KR2020/005262
Other languages
French (fr)
Korean (ko)
Other versions
WO2020231030A2 (en
Inventor
김윤태
남영도
신희순
이소영
김재구
임은영
송은지
엄기안
홍성운
임미형
연성흠
손락호
박채리
음현애
Original Assignee
한국식품연구원
(주)휴온스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국식품연구원, (주)휴온스 filed Critical 한국식품연구원
Publication of WO2020231030A2 publication Critical patent/WO2020231030A2/en
Publication of WO2020231030A3 publication Critical patent/WO2020231030A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/113—Acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to a composition comprising Lactobacillus acidophilus for preventing, alleviating, or treating nervousness, formication, insomnia, vertigo, or fatigue in menopausal women. As a result of applying Lactobacillus acidophilus YT1 strain according to the present invention to a food which is consumed by the human body, it was observed that nervousness, formication, insomnia, vertigo, or fatigue was alleviated in menopausal women who had taken a food containing the strain. Therefore, the composition comprising the Lactobacillus acidophilus according to the present invention is expected to be advantageously applied to the treatment, alleviation, or treatment of nervousness, formication, insomnia, vertigo, or fatigue in menopausal women.
PCT/KR2020/005262 2019-05-14 2020-04-21 Composition comprising lactobacillus acidophilus for preventing, alleviating, or treating nervousness, formication, insomnia, vertigo, or fatigue in menopausal women WO2020231030A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190056539A KR102317304B1 (en) 2019-05-14 2019-05-14 Composition for preventing, improving, or treating of hypersensitivity, ant hallucination, insomnia, dizziness, or tiredness of menopausal female comprising Lactobacillus acidophilus
KR10-2019-0056539 2019-05-14

Publications (2)

Publication Number Publication Date
WO2020231030A2 WO2020231030A2 (en) 2020-11-19
WO2020231030A3 true WO2020231030A3 (en) 2021-02-04

Family

ID=73289644

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2020/005262 WO2020231030A2 (en) 2019-05-14 2020-04-21 Composition comprising lactobacillus acidophilus for preventing, alleviating, or treating nervousness, formication, insomnia, vertigo, or fatigue in menopausal women

Country Status (2)

Country Link
KR (1) KR102317304B1 (en)
WO (1) WO2020231030A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4289438A1 (en) * 2021-02-03 2023-12-13 Kookmin University Industry Academy Cooperation Foundation Composition for preventing, alleviating or treating sleep disorders, containing, as active ingredient, gut microbiota or extracellular vesicles derived therefrom

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100016101A (en) * 2007-03-30 2010-02-12 산토리 홀딩스 가부시키가이샤 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions
US20110236358A1 (en) * 2008-12-12 2011-09-29 Stefano Sala Composition comprising isoflavones
KR20170028486A (en) * 2015-09-03 2017-03-14 호서대학교 산학협력단 Composition for Preventing, Treating or Improving Menopausal Syndrome comprising Sparassis crispa Wulf.: Fr. and Lactic Acid Bacteria as Active Ingredient
KR20180018422A (en) * 2016-08-12 2018-02-21 한국식품연구원 Composition for preventing or treating of climacterium comprising Lactobacillus acidophilus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101845245B1 (en) * 2016-04-05 2018-04-04 (주)아모레퍼시픽 Composition for improving woman menopause symptom comprising extract of Sasa quelpaertensis Nakai

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100016101A (en) * 2007-03-30 2010-02-12 산토리 홀딩스 가부시키가이샤 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions
US20110236358A1 (en) * 2008-12-12 2011-09-29 Stefano Sala Composition comprising isoflavones
KR20170028486A (en) * 2015-09-03 2017-03-14 호서대학교 산학협력단 Composition for Preventing, Treating or Improving Menopausal Syndrome comprising Sparassis crispa Wulf.: Fr. and Lactic Acid Bacteria as Active Ingredient
KR20180018422A (en) * 2016-08-12 2018-02-21 한국식품연구원 Composition for preventing or treating of climacterium comprising Lactobacillus acidophilus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EUN YEONG LIM; JAE GOO KIM; SUN YOUNG JUNG; EUN-JI SONG; SO-YOUNG LEE; HEE SOON SHIN; YOUNG-DO NAM; YUN TAI KIM: "Attenuating Effects of Lactobacillus acidophilus YT1 on Menopausal Symptoms in Ovariectomized Rats", JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION, vol. 47, no. 12, 1 January 2018 (2018-01-01), pages 1225 - 1233, XP009525589, ISSN: 2288-5978, DOI: 10.3746/jkfn.2018.47.12.1225 *

Also Published As

Publication number Publication date
KR20200131657A (en) 2020-11-24
WO2020231030A2 (en) 2020-11-19
KR102317304B1 (en) 2021-10-26

Similar Documents

Publication Publication Date Title
MX2019009079A (en) Novel lactic acid bacteria and use thereof.
MX2017002285A (en) Gamma-diketones for treatment and prevention of aging skin and wrinkles.
WO2013002584A3 (en) Combination of effective substances causing synergistic effects of multiple targeting and use thereof
WO2012005876A3 (en) Compositions and methods for stimulating magp-1 to improve the appearance of skin
MX2021016034A (en) Compositions and methods of treating a th2-mediated condition using prevotella.
MX2011009751A (en) Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2.
MX2012000034A (en) Methods for treating or preventing fatigue.
WO2011103528A3 (en) Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1
SG11202111168UA (en) Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes
MX2018002507A (en) Method for inhibiting absorption of and/or promoting excretion of lipids using d-psicose.
WO2019045287A3 (en) Composition comprising fraction of rosa multiflora extract as effective ingredient for preventing, alleviating, or treating immune disease
MX2015006120A (en) Novel orally bioavailable breathing control modulating compounds, and methods of using same.
WO2009031099A3 (en) Cosmetic use of microorganisms
CN107405369A8 (en) Composition comprising bacterium and use it for treating and/or prevent enterogastric diseases, the method for metabolic disease and/or Other diseases
WO2020231030A3 (en) Composition comprising lactobacillus acidophilus for preventing, alleviating, or treating nervousness, formication, insomnia, vertigo, or fatigue in menopausal women
PH12018550110A1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
MX2022012692A (en) Compositions comprising nanoparticles, method of making and uses thereof.
PH12020551071A1 (en) Compositions and methods for treating retinal disorders
MX2021007885A (en) Methods and compositions for treating skin and hair disorders.
WO2020089440A3 (en) Prevention of the oxidation of perfumery raw materials and food raw materials
MX2023006146A (en) Designed bacterial compositions for treating graft-versus-host-di sease.
GEP20207089B (en) Histamine-producing bacterial strains and their use in cancer
WO2020231031A3 (en) Composition comprising lactobacillus acidophilus for preventing, alleviating, or treating arthromyalgia, headaches, or vaginal dryness in climacteric women
MX2021004860A (en) Novel pyridazines.
MX2020008991A (en) Methods for altering body composition.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20805511

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20805511

Country of ref document: EP

Kind code of ref document: A2